Cellectis Inc - Company & Market Research Reports

Cellectis is a gene-editing company that develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. The company designs novel products including immune therapies for cancer and enzymes which can add DNA at targeted places in genomes. Its lead product candidate is UCART19, an allogeneic T-cell product candidate for the treatment of CD19 expressing hematologic malignancies which develop in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia. Cellectis S.A. was founded in 1999 and is based in Paris, France.

The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More - Product Thumbnail Image

The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More

  • Report
  • 123 Pages
From
Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) - Reagents & Tools, Services, Cell Lines, Models - Product Thumbnail Image

Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) - Reagents & Tools, Services, Cell Lines, Models

  • Report
  • 167 Pages
From
Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030

  • Report
  • 449 Pages
From
Gene Therapy Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Gene Therapy Market (2nd Edition), 2018-2030

  • Report
  • 555 Pages
From
Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy - Product Thumbnail Image

Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy

  • Report
  • 273 Pages
From
Cell Therapy Manufacturing Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Cell Therapy Manufacturing Market (2nd Edition), 2018-2030

  • Report
  • 444 Pages
From
Global Gene Therapy Market Analysis & Forecast to 2022 - Product Thumbnail Image

Global Gene Therapy Market Analysis & Forecast to 2022

  • Report
  • 310 Pages
From
BCMA Targeted Therapies, 2017-2030 - Product Thumbnail Image

BCMA Targeted Therapies, 2017-2030

  • Report
  • 143 Pages
From
Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends - Product Thumbnail Image

Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends

  • Report
  • 194 Pages
From
Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing - Product Thumbnail Image

Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing

  • Report
  • 211 Pages
From
Genome Editing Global Market-Forecast to 2022 - Product Thumbnail Image

Genome Editing Global Market-Forecast to 2022

  • Report
  • 273 Pages
From
Global CAR T Cell Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Thumbnail Image

Global CAR T Cell Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • Report
From
Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Cancer, Genetic Disorders, Infectious Diseases, CVD, Neuro Disorders), By Vector Type (Viral, Non-Viral), By Region, and Segment Forecasts, 2018 - 2026 - Product Thumbnail Image

Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Cancer, Genetic Disorders, Infectious Diseases, CVD, Neuro Disorders), By Vector Type (Viral, Non-Viral), By Region, and Segment Forecasts, 2018 - 2026

  • Report
  • 120 Pages
From
Global CAR T Cell Therapy Market & Clinical Trials Insight 2022 - Product Thumbnail Image

Global CAR T Cell Therapy Market & Clinical Trials Insight 2022

  • Drug Pipelines
  • 240 Pages
From
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use, And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use, And Segment Forecasts, 2014 - 2025

  • Report
  • 150 Pages
From
The Market and Potential for CRISPR/Cas9 Gene Editing - Product Thumbnail Image

The Market and Potential for CRISPR/Cas9 Gene Editing

  • Report
  • 101 Pages
From
Global CRISPR Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023 - Product Thumbnail Image

Global CRISPR Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

  • Report
  • 140 Pages
From
Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2014 - 2025

  • Report
  • 185 Pages
From
Genome Editing: Technologies and Global Markets - Product Thumbnail Image

Genome Editing: Technologies and Global Markets

  • Report
  • 129 Pages
From
Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • 618 Pages
From
Loading Indicator
adroll